We are live on ! Find out more
BC

Birchview Capital Portfolio holdings

AUM $176M
1-Year Est. Return 95.04%
This Fund
S&P 500
This Quarter Est. Return
+9.58%
1 Year Est. Return
+95.04%
3 Year Est. Return
+233.14%
5 Year Est. Return
+280.2%
10 Year Est. Return
+1,023.63%
AUM
$155M
AUM Growth
+$7.79M
Cap. Flow
-$3.04M
Cap. Flow %
-1.96%
Top 10 Hldgs %
83.08%
Holding
58
New
5
Increased
5
Reduced
13
Closed
4

Top Buys

Rank Stock Value
1
DOVA
Dova Pharmaceuticals, Inc. Common Stock
DOVA
+$714K
2
CMTA
Clementia Pharmaceuticals Inc.
CMTA
+$568K
3
OPK icon
Opko Health
OPK
+$552K
4
ARVN icon
Arvinas
ARVN
+$494K
5
ODT
Odonate Therapeutics, Inc. Common Stock
ODT
+$408K

Top Sells

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$1.41M
2
OXFD
Oxford Immunotec Global PLC Ordinary Shares
OXFD
+$815K
3
CFRX
ContraFect Corporation
CFRX
+$576K
4
VCYT icon
Veracyte
VCYT
+$551K
5
OVV icon
Ovintiv
OVV
+$441K

Sector Composition

Rank Sector Weight
1 Healthcare 96.81%
2 Energy 2.32%
3 Consumer Staples 0.25%
4 Industrials 0.16%
5 Consumer Discretionary 0.02%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CYTK icon
51
Cytokinetics
CYTK
$10.9B
$99K 0.06%
10,000
– –
TGTX icon
52
TG Therapeutics
TGTX
$8.39B
$84K 0.05%
15,000
– –
BIOL
53
DELISTED
Biolase, Inc.
BIOL
$83K 0.05%
16
-38
-70% -$152K
WKHS icon
54
Workhorse Group
WKHS
$30.1M
$27K 0.02%
8
– –
APTX
55
DELISTED
Aptinyx Inc. Common Stock
APTX
– –
-10,000
Closed -$242K
CLVS
56
DELISTED
Clovis Oncology, Inc.
CLVS
– –
-5,000
Closed -$227K
CELGZ
57
DELISTED
Celgene Corporation Contingent Value Rights
CELGZ
– –
-241,877
Closed -$98K
1 2
3

Similar funds

RWA
Resolute Wealth Advisor Findlay, Ohio $176M AUM
BAM
Boyar Asset Management New York $176M AUM 20.04% 1-Year Est. Return
TIM
Tevis Investment Management Plano, Texas $176M AUM 18.14% 1-Year Est. Return
TFCM
Taylor Frigon Capital Management Scottsdale, Arizona $176M AUM 24.25% 1-Year Est. Return
FPW
Flywheel Private Wealth Los Altos, California $176M AUM 26.12% 1-Year Est. Return
LWM
Lifetime Wealth Management Rockwall, Texas $176M AUM
PFA
Providence Financial Advisors Overland Park, Kansas $175M AUM
DAM
Draper Asset Management Smithtown, New York $176M AUM 37.45% 1-Year Est. Return

Birchview Capital's Q3 2018 Portfolio in Review

As of Q3 2018, Birchview Capital held 58 positions worth $155M, up 5.3% from $147M the previous quarter. Its ten largest holdings account for 83% of the portfolio.

Birchview Capital's Q3 2018 filing shows 5 new, 5 increased, 13 reduced and 4 closed positions. Its largest new stake was Dova Pharmaceuticals, Inc. Common Stock: 30,000 shares worth $629K. The largest sale was Celgene Corp, an estimated $1.41M.

By sector, the portfolio is most concentrated in Healthcare at 97% of assets, up from 96% a quarter earlier, followed by Energy and Consumer Staples.

  • Birchview Capital's largest Q3 2018 buy was Dova Pharmaceuticals, Inc. Common Stock: 30,000 shares worth $629K.
  • Birchview Capital added most to Clementia Pharmaceuticals Inc. in Q3 2018, an estimated $568K increase.
  • Birchview Capital's biggest Q3 2018 reduction was Celgene Corp, cutting an estimated $1.41M.
  • Birchview Capital fully exited Aptinyx Inc. Common Stock in Q3 2018, selling an estimated $242K.
  • Birchview Capital's ten largest holdings make up 83% of its $155M portfolio in Q3 2018.
  • Birchview Capital opened 5 new positions and closed 4 in Q3 2018.
  • Birchview Capital's portfolio value rose 5.3% quarter-over-quarter to $155M.

Based on Birchview Capital's 13F filing for Q3 2018, filed 1 Nov 2018.